| Verified against primary record | |
| Legislative instrument | Senate Bill No. 58, the Medical Tourism Act of 2007, Fourteenth Congress, First Regular Session[1] |
|---|---|
| Sponsor | Senator Manuel Lito M. Lapid[1] |
| Status | A bill with an explanatory note; the document consulted is not an enacted statute[1] |
| Body it would create | A National Task Force on Medical Tourism co-chaired by the health and tourism departments[1] |
| Malpractice provisions | A legal support mechanism for foreign patients, waived filing fees for malpractice victims, and rules for prosecuting providers who commit malpractice against medical tourists[1] |
| Finance provision | A Medical Tourism Credit Facility at the Land Bank of the Philippines for low-interest facility upgrade loans[1] |
| Philippine patient or revenue target | None; every figure in the explanatory note describes a competitor country[1] |
| Stated workforce aim | To reverse the current outward migration of Philippine professionals and bring back health workers trained abroad[1] |
| Independently reported | |
| Regional leaders at the time | Thailand about 1 million visitors a year, India 500,000, Singapore 350,000[3] |
| Bands apply only to the rows beneath them. The primary-record band describes what the bill says, not what Philippine law now is: the document is a Senate bill from 2007 and no enacted statute, implementing rules or programme outcome was located. No Philippine count of foreign patients, no revenue figure and no outbound figure was found in any source. No typical cost range is given. | |
Medical tourism in the Philippines has an unusually detailed legislative proposal and almost no statistics. Senate Bill No. 58 of 2007 would have created a national task force, a state credit facility for hospital upgrades, and a legal support mechanism for foreign patients bringing malpractice claims. Its explanatory note quantifies Singapore, India, Thailand and Malaysia, and sets no Philippine target at all.
What the bill would do
Senate Bill No. 58, titled an Act Instituting a Comprehensive and Holistic Mechanism for the Promotion of Medical Tourism in the Country and for Other Purposes and known as the Medical Tourism Act of 2007, was filed in the Fourteenth Congress by Senator Manuel Lito M. Lapid. It declares a state policy to promote the right to health and to institutionalise a comprehensive medical tourism programme.[1]
It would create a National Task Force on Medical Tourism co-chaired by the Department of Health and the Department of Tourism, with members from the trade, foreign affairs, justice and interior departments, the Land Bank, the Civil Service Commission and private sectors. It requires a national medical tourism website, a national marketing programme with a plan due within six months, an annual conference, and a two-year study of the sector covering six government-run hospitals including the Philippine Heart Center, the Lung Center of the Philippines and the National Kidney and Transplant Institute.[1]
On accreditation, section 3 places a national accreditation and affiliation programme for hospitals and health providers with the health department, assessing quality of care, with optional tourism accreditation from the tourism department. Section 7 allows the task force to issue accreditation certificates and requires it to set guidelines for prosecuting providers who exploit medical tourists. Section 16 directs the trade department to help hospitals obtain foreign accreditation, and section 19 requires tourism accreditation rules for travel and tour facilities serving medical tourists.[1]
The malpractice provisions
The bill’s most distinctive feature is that it addresses what happens when treatment goes wrong. It requires a legal support mechanism for foreign patients facing medical malpractice, waives filing fees for malpractice victims bringing criminal or civil actions, and directs the justice department with the health department to issue rules on prosecuting providers who commit malpractice against medical tourists.[1]
That is rare and worth marking. The standard criticism of medical travel is that a patient harmed abroad has no practical remedy, because litigation in a foreign jurisdiction in an unfamiliar language is prohibitively expensive. A destination country proposing to waive filing fees for foreign malpractice claimants and to build a support mechanism for them is addressing the objection directly rather than deflecting it, and no comparable provision was found in any other national instrument examined for this site apart from the reporting duties in Israeli law.
Whether any of it took effect is a separate question. The document consulted is a bill with an explanatory note, not an enacted law, and no Philippine statute, implementing rules, task force report or programme evaluation was located for this article. Nothing here should be read as a description of current Philippine law.
A note full of other countries’ numbers
The explanatory note is built almost entirely on competitor figures. It gives Singapore more than 250,000 patients a year with nearly half from the Middle East; India about 500,000 foreign patients expected that year against 150,000 in 2002, growing 30 per cent annually, with experts estimating 2.2 billion dollars a year by 2012; one Bangkok hospital taking 150,000 treatment seekers from abroad in 2005 and Thai medical tourism estimated to earn 36.4 billion baht in 2006; and Malaysia with 100,000 patients in the first half of 2005 and receipts expected to reach 590 million dollars within five years. It presents cost comparisons such as a heart valve replacement at about 10,000 dollars in India against over 200,000 dollars in the United States.[1]
It sets no Philippine target and gives no Philippine baseline. A legislative case for entering a market that quantifies four competitors and not the proposing country is making an argument from opportunity rather than from capability, and it leaves no measure against which the programme could later have been assessed.[1]
The competitor scale is independently corroborated. A 2015 briefing by an economist in the United States International Trade Commission’s Office of Industries, published as the author’s own views and not the Commission’s, names the leading global providers as Thailand with about 1 million visitors a year, India with 500,000 and Singapore with 350,000, against a global estimate of roughly 3 million patients travelling for healthcare each year.[3]
The workforce argument
The note argues the measure would help reverse the current outward migration of Philippine professionals, encourage doctors to stay, and bring back health workers trained abroad. Section 3 cites short waiting times for critical treatments as a goal for both foreign and local patients, and the note points to long public-system waits in Britain and Canada, where it says a hip replacement can take a year or more, as a reason for medical tourism demand. The document gives no emigration statistics.[1]
The Philippines is one of the world’s largest exporters of nurses and doctors, so a proposal to retain health workers by building a sector that competes for the same workers raises an obvious question the note does not address: whether domestic demand for clinicians from foreign patients draws staff away from Philippine public provision rather than back into it. The note asserts the benign outcome without argument.
The Centers for Disease Control and Prevention lists cosmetic surgery, dental care, cancer treatment, fertility treatment and organ transplantation as the procedures most often sought abroad, and states that accreditation does not guarantee a good outcome, which bears on the bill’s reliance on accreditation as its quality mechanism.[2]
Limits of the evidence
No Philippine Department of Health or Department of Tourism statistic on foreign patients was located, no revenue figure, no accreditation register and no outbound patient figure. Whether Senate Bill No. 58 or any successor was enacted could not be established from the sources consulted, and nothing here describes current law or current practice. The competitor figures in the explanatory note date from 2002 to 2006 and are reproduced as what the note says rather than as current data. Nothing has been estimated.
See also
- Medical tourism and health workforce migration, the tension the bill asserts away
- Medical tourism in Thailand, the regional leader the note measures itself against
- Medical tourism and public subsidies, including the proposed state credit facility
- Medical tourism and local access to care, given six government hospitals in scope
- Medical tourism in Israel, the other jurisdiction examined here that legislated on the subject
References
- Senate of the Philippines. Senate Bill No. 58, An Act Instituting a Comprehensive and Holistic Mechanism for the Promotion of Medical Tourism in the Country and for Other Purposes (Medical Tourism Act of 2007). Fourteenth Congress, First Regular Session, sponsored by Senator Manuel Lito M. Lapid. Verified against primary record: the document was opened and its identification as a Senate bill with an explanatory note, the declared state policy to promote the right to health and institutionalise a comprehensive medical tourism programme, the creation of a National Task Force on Medical Tourism co-chaired by the Department of Health and Department of Tourism with named member agencies including the Land Bank of the Philippines and the Civil Service Commission, the requirements for a national medical tourism website, a national marketing programme with a plan due within six months and an annual conference, the required two-year study covering six government-run hospitals including the Philippine Heart Center, the Lung Center of the Philippines and the National Kidney and Transplant Institute, the integration of Republic Act No. 8424 on traditional and alternative medicine, the accreditation provisions in sections 3, 7, 16 and 19, the legal support mechanism for foreign patients facing medical malpractice, the waiver of filing fees for malpractice victims bringing criminal or civil actions, the section 17 requirement for rules on prosecuting providers who commit malpractice against medical tourists, the Medical Tourism Credit Facility at the Land Bank for low-interest facility upgrade loans, the section 11 requirement for visa implementing rules within six months, the explanatory note’s figures for Singapore, India, Thailand and Malaysia and its cost comparison for heart valve replacement, the absence of any Philippine patient or revenue target or baseline, the stated aim of reversing outward migration of Philippine professionals and bringing back health workers trained abroad, the section 3 goal of short waiting times for both foreign and local patients, the reference to long public-system waits in Britain and Canada, and the absence of any emigration statistics were read directly. The document is a bill, not an enacted statute, and no filing date appears on the page. Retrieved 23 October 2026.
- Stoney, R. J. and Leidel, L. Medical Tourism. CDC Yellow Book: Health Information for International Travel, 2026 edition, United States Centers for Disease Control and Prevention. Page dated 23 April 2025. Independently reported: the chapter was opened and the listing of cosmetic surgery, dental care, cancer treatment, fertility treatment and organ transplantation as the procedures most often sought abroad, and the statement that accreditation does not guarantee a good outcome, were read directly. Retrieved 23 October 2026.
- Chambers, A. Trends in U.S. Health Travel Services Trade. Office of Industries, United States International Trade Commission, Executive Briefing on Trade, August 2015. Independently reported: the briefing was opened and the identification of the leading global providers as Thailand with about 1 million visitors a year, India with 500,000 and Singapore with 350,000, and the global estimate that roughly 3 million patients are thought to travel for healthcare each year, were read directly. The briefing states that the views expressed are those of the author and not those of the Commission. Retrieved 23 October 2026.
Sourcing note: the primary-record band here describes what a 2007 Senate bill proposed, and the entry states repeatedly that this is not current Philippine law, because no enacted statute or implementing rules were located. The competitor figures are reproduced as the note’s own content, with their 2002 to 2006 vintage stated, not as present-day data. The question the note leaves unaddressed about workforce competition is identified as unaddressed rather than answered here. Nothing has been estimated.